Value of direct-to-consumer drug advertising oversold, study finds

Direct-to-consumer advertising may not be giving big pharma such a big bang for their buck after all. Despite the billions spent on bringing drug marketing campaigns straight into patients' living rooms, such strategies have a modest effect at best—and in some cases, no effect at all.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news139571647.html">Value of direct-to-consumer drug advertising oversold, study finds</a></p> <p>Direct-to-consumer advertising may not be giving big pharma such a big bang for their buck after all. Despite the billions spent on bringing drug marketing campaigns straight into patients' living rooms, such strategies have a modest effect at best—and in some cases, no effect at all.</p>